| Quote | Spy APT NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Alpha Pro Tech Ltd. Posts Q4 EPS of $0.15, Tops Views by 3c
APT Linked by StreetInsider - March 09, 04:11PM from (www.streetinsider.com) more ...
Swine Flu Antiviral Helps BioCryst Crush Estimates in Q4
BCRX APT RHHBY NVAX INO GNBT SVA NVS SNY Linked by tickerspy blog - February 04, 10:35AM from (www.tickerspy.com) While select swine flu players have seen their pops and drops, BioCryst Pharmaceuticals (BCRX) may have emerged as the small-cap champion of the 2009 pandemic. more ...
Big Pullback for Top Swine Flu Small-Caps
VICL BCRX APT RHHBY DVAX SVA NVS GSK Linked by tickerspy blog - November 17, 12:18PM from (www.tickerspy.com) The H1N1 vaccine sector slipped on Tuesday, with some of the less speculative names being hit the worst. more ...
The $2000 Swine Flu Drug
BAX GILD BCRX APT RHHBY HEB DVAX INO SVA Linked by tickerspy blog - November 05, 09:53AM from (www.tickerspy.com) The peramivir pricing speculation is over, and the first order has been shipped. The U.S. FDA issued more ...
Swine Flu Stock Picking Rewards Winners Handsomely
BAX CLX GILD BCRX APT NVAX PURE NVS GSK Linked by tickerspy blog - November 02, 11:34AM from (www.tickerspy.com) After a week in the red, select swine flu stocks pushed higher on Monday. Last week Alpha Pro Tech (APT) more ...
Swine Flu Small-Cap Jumps on FDA Announcement
VICL GILD BCRX APT RHHBY HEB DVAX GSK Linked by tickerspy blog - October 26, 09:43AM from (www.tickerspy.com) An Alabama-based small-cap biotech play was granted emergency use authorization for its H1N1 antiviral. more ...
WHO Stirs Up Swine Flu Fears
KMB MMM CAH BCRX APT RHHBY SVA NVS GSK Linked by tickerspy blog - September 18, 10:43AM from (www.tickerspy.com) The World Health Organization warned Friday that the previously forecast annual swine flu vaccine production of 4.9 billion doses will be much lower than expected. more ...
BioCryst takes on Tamiflu
VICL APT RHHBY HEB PURE INO SVA Linked by tickerspy blog - September 14, 11:43AM from (www.tickerspy.com) Peramivir could be the next swine flu-fighting one-dose wonder. BioCryst Pharmaceuticals (NADSAQ: BCRX) more ...
In Absence of Flu News, Vaccine Stocks Still Soar
QDEL APT HEB DVAX CPHD GNBT NVS GSK IMA Linked by tickerspy blog - September 10, 10:43AM from (www.tickerspy.com) It's not all swine flu for these vaccine companies, and Thursday's moves proved it. Safety concerns put more ...
One-Dose Swine-Flu Vaccines Could Halve Global Supply Issue
BAX VICL BCRX APT NVAX SVA NVS SNY GSK Linked by tickerspy blog - September 03, 10:13AM from (www.tickerspy.com) A little H1N1 vaccine goes a long way according to Novartis (NVS), but what does it mean for global supply? more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|